NDTV Profit's special research section collates quality and in-depth equity and economy research reports from across India's top brokerages, asset managers and research agencies. These reports offer NDTV Profit's subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
Camlin Fine Sciences Ltd.'s Q3 FY24 Ebitda came ~16% below our estimate on account of continued global challenges, major pricing pressure across the portfolio and slower than expected ramp up of Vanillin.
Vanillin, a major future earnings driver for Camlin Fine Sciences apart from the blends business, is facing pricing pressure due to increased Chinese competition.
The management is banking on FY25 basis, a gradual recovery over the next two-three quarters, ramp up of Vanillin and continued momentum in the Blends business.
Maintain 'Buy' with a revised target price of Rs 150 (18 times earning price on December 25E)
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
